Information
-
Patent Application
-
20070213313
-
Publication Number
20070213313
-
Date Filed
August 17, 200618 years ago
-
Date Published
September 13, 200717 years ago
-
Inventors
-
Original Assignees
-
CPC
-
US Classifications
-
International Classifications
Abstract
An amino acid in solution is precipitated with concentrated hydrochloric acid and isolated as the dihydrochloride monohydrate. Said dihydrochloride is redissolved and reprecipitated by adding a solvent.
Claims
- 1. A process for producing sterile cefepime dihydrochloride monohydrate, according to which a cefepime solution obtained from the synthesis is decolorized with carbon, treated with concentrated HCl to pH 0.4-0.6 at a temperature between 15° and 30° C., then allowed to crystallize for 15-60 minutes and subsequently diluted by adding a water miscible organic solvent over 60-90 minutes at 20°-30° C. until complete precipitation of the crude cefepime dihydrochloride monohydrate, which is then filtered off, redissolved in a solvent chosen from the group consisting of methanol and water at 15°-25° C., filtered sterilely, diluted with the same already used organic solvent over 30-60 minutes in order to induce crystallization, and finally again diluted with the same solvent over 90-150 minutes to complete crystallization of the sterile cefepime dihydrochloride monohydrate, which is filtered off, washed with acetone and dried under vacuum to a K.F. between 3.0% and 4.5%.
- 2. A process for producing sterile cefepime dihydrochloride monohydrate, wherein a particularly pure aqueous solution of cefepime obtained from the synthesis is decolorized with carbon, filtered sterilely, treated with concentrated HCl to pH 0.4-0.6 at a temperature between 15° and 30° C., then allowed to crystallize for 15-60 minutes and subsequently diluted by adding a water miscible organic solvent over 60-90 minutes at 20°-30° C. until complete precipitation of the sterile cefepime dihydrochloride monohydrate, which is then filtered off, washed with acetone and dried under vacuum to a K.F. between 3.0% and 4.5%.
- 3. A process as claimed in claim 1, wherein said acidification with concentrated HCl is undertaken until pH 0.5 is achieved.
- 4. A process as claimed in claim 1, wherein said organic solvent is acetone.
- 5. A process as claimed in claim 2, wherein said organic solvent is acetone.
- 6. A process as claimed in claim 1, wherein the crude cefepime dihydrochloride monohydrate is dissolved in methanol, to be then filtered sterilely.
- 7. A process as claimed in claim 4, wherein the crude cefepime dihydrochloride monohydrate is dissolved in methanol, to be then filtered sterilely.
- 8. A process as claimed in claim 1, wherein the crude cefepime dihydrochloride monohydrate is dissolved in water, to be then filtered sterilely.
- 9. A process as claimed in claim 4, wherein the crude cefepime dihydrochloride monohydrate is dissolved in water, to be then filtered sterilely.
- 10. A process as claimed in claim 1 wherein the sterile cefepime dihydrochloride monohydrate obtained has a density about double that of the product prepared by the known method.
Priority Claims (1)
Number |
Date |
Country |
Kind |
MI2006A 000422 |
Mar 2006 |
IT |
national |